We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+676.14%
AUM
$865B
AUM Growth
-$62.5B
Cap. Flow
-$15.6B
Cap. Flow %
-1.8%
Top 10 Hldgs %
34.38%
Holding
3,202
New
115
Increased
2,022
Reduced
804
Closed
71

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.82B
2
SE icon
Sea Limited
SE
+$1.38B
3
CSCO icon
Cisco
CSCO
+$1.16B
4
NFLX icon
Netflix
NFLX
+$1.14B
5
IR icon
Ingersoll Rand
IR
+$1.03B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.54B
2
AMZN icon
Amazon
AMZN
+$1.75B
3
APH icon
Amphenol
APH
+$1.65B
4
KLAC icon
KLA
KLAC
+$1.5B
5
XEL icon
Xcel Energy
XEL
+$1.38B

Sector Composition

Rank Sector Weight
1 Technology 33.6%
2 Financials 11.17%
3 Healthcare 11.1%
4 Communication Services 10.25%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PINS icon
601
Pinterest
PINS
$12.4B
$105M 0.01%
5,737,832
-22,071,861
-79% -$461M
CYTK icon
602
Cytokinetics
CYTK
$11B
$104M 0.01%
1,584,321
-345,798
-18% -$22M
TGT icon
603
Target
TGT
$62.1B
$104M 0.01%
858,134
-12,997
-1% -$1.47M
EPAM icon
604
EPAM Systems
EPAM
$4.69B
$103M 0.01%
761,228
-22,873
-3% -$3.91M
UUUU icon
605
Energy Fuels
UUUU
$2.82B
$102M 0.01%
5,610,361
-993,988
-15% -$20.6M
PRIM icon
606
Primoris Services
PRIM
$4.69B
$102M 0.01%
714,521
+179,978
+34% +$26.4M
HUN icon
607
Huntsman Corp
HUN
$2.24B
$101M 0.01%
7,614,731
+7,490,190
+6,014% +$90.8M
ALHC icon
608
Alignment Healthcare
ALHC
$4.02B
$101M 0.01%
5,741,306
+275,189
+5% +$5.53M
SOMN
609
The Southern Company 2025 Series A Corp Units
SOMN
0
AIT icon
610
Applied Industrial Technologies
AIT
$12.8B
$101M 0.01%
379,767
+121,832
+47% +$33.2M
AEP icon
611
American Electric Power
AEP
$73.7B
$101M 0.01%
767,254
-11,751
-2% -$1.47M
QXO
612
QXO Inc
QXO
$14.2B
$100M 0.01%
5,150,196
+3,970,861
+337% +$90.8M
COIN icon
613
Coinbase
COIN
$41.7B
$99.2M 0.01%
568,099
-103,502
-15% -$20.4M
IRON icon
614
Disc Medicine
IRON
$2.83B
$99.1M 0.01%
1,549,350
-148,655
-9% -$10.3M
LLYVK icon
615
Liberty Live Group Series C
LLYVK
$9.11B
$98.3M 0.01%
1,044,537
-297,017
-22% -$26.7M
ITW icon
616
Illinois Tool Works
ITW
$81.4B
$97.6M 0.01%
375,023
-198,308
-35% -$54M
EVR icon
617
Evercore
EVR
$13.1B
$97.5M 0.01%
326,665
-290,667
-47% -$95.2M
FTAI icon
618
FTAI Aviation
FTAI
$22.2B
$97.5M 0.01%
397,827
-125,865
-24% -$33.3M
WBD icon
619
Warner Bros
WBD
$64.6B
$97.3M 0.01%
3,543,252
-79,376
-2% -$2.22M
NXST icon
620
Nexstar Media Group
NXST
$5.6B
$96.8M 0.01%
535,218
+308,137
+136% +$69.1M
GPCR icon
621
Structure Therapeutics
GPCR
$3.49B
$96.4M 0.01%
2,000,696
+329,558
+20% +$22.6M
DNTH icon
622
Dianthus Therapeutics
DNTH
$5.68B
$96.3M 0.01%
1,146,948
+530,915
+86% +$30.7M
APGE icon
623
Apogee Therapeutics
APGE
$10.2B
$96.2M 0.01%
1,143,152
-93,983
-8% -$6.83M
HEI icon
624
HEICO Corp
HEI
$48.9B
$94.9M 0.01%
346,010
+8,946
+3% +$2.88M
FROG icon
625
JFrog
FROG
$9.71B
$94.8M 0.01%
2,019,029
-664,124
-25% -$32.6M

Similar funds

T. Rowe Price Associates's Q1 2026 Portfolio in Review

As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
  • T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
  • T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
  • T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
  • T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.